Social contexts, social media, and human subjects research

American Journal of Bioethics

Volumn 11, Issue 5, 2011, Pages 35-36

  Foulkes, Mary ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL (TOPIC); ETHICS; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNET; MASS MEDIUM; PUBLIC OPINION; RESEARCH SUBJECT; SOCIAL ENVIRONMENT; SOCIAL SUPPORT;

AIDS VACCINES; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIALS AS TOPIC; HIV INFECTIONS; HUMAN EXPERIMENTATION; HUMANS; INTERNET; MASS MEDIA; PUBLIC OPINION; RESEARCH SUBJECTS; SOCIAL ENVIRONMENT; SOCIAL SUPPORT;

EID: 79957795976     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2011.560358     Document Type: Article

References (12)

1. Abel, K., L. Compton, T. Rourke, et al. 2003.Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon. Journal of Virology 77(5): 3099-3118.
2. Biros, M. H. 2011. The people speak: Community consultation in emergency research. Annals of Emergency Medicine 57: epubl.
3. Food and Drug Administration. 1996. 21 CFR part 50.24. Protection of human subjects: informed consent-final rule. Federal Register 61:51498-51533.
4. Food and Drug Administration. 2006. FDA guidance for institutional review boards, clinical investigators and sponsors. Exception from Informed Consent Requirements for Emergency Research-Draft Guidance. Available at: http://www.fda.gov/RegulatoryInformation/Guidances/ucm127625.htm#viii
5. Francis, D. P., W. L. Heyward, V. Popovic, et al. 2003. Candidate HIV/AIDS vaccines: Lessons learned from the world's first phase III efficacy trials. AIDS 17(2): 147-156.
6. Gordon, J. B., R. J. Levine, C.M. Mazure, P. E. Rubin, B. R. Schaller, and J. L. Young. 2011. Social contexts influence ethical considerations of research. American Journal of Bioethics 11(5): 24-30.
7. Lagakos, S. W., and A. R. Gable. 2008. Methodological challenges in biomedical HIV prevention trials. Washington, DC: National Academies Press.
8. Love/Avon Army of Women. 2008. Available at: http://www.armyofwomen.org
9. Nass, S. J., H. L. Moses, and J. Mendelsohn (eds.). 2011. A National Cancer Institute trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. Washington, DC: National Academies Press.
10. Patlak, M. 2010. Competitors try collaboration to speed drug development. Journal of the National Cancer Institute 102(12): 841-843.
11. Valdez, B., and J. Lane. 2008. The science of science policy: A federal roadmap. Available at: http://www.whitehouse.gov/files/documents/ostp/NSTC%20Reports/39924PDF%20Proof.pdf
12. WHO/UNAIDS/IAVI ExpertGroup Consultation. 2007. Phase IIBTOC (test of concept) trials as a novel strategy for evaluation of preventive HIV vaccines. AIDS 21(4): 539-546.